AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 35 filers reported holding AQUINOX PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $402,000 | -12.4% | 170,711 | +0.0% | 0.00% | – |
| Q1 2019 | $459,000 | -37.6% | 170,663 | -49.9% | 0.00% | – |
| Q4 2018 | $736,000 | +51.4% | 340,966 | +105.2% | 0.00% | – |
| Q3 2018 | $486,000 | +10.5% | 166,203 | 0.0% | 0.00% | – |
| Q2 2018 | $440,000 | -78.4% | 166,203 | +15.1% | 0.00% | -100.0% |
| Q1 2018 | $2,033,000 | +42.9% | 144,400 | +19.3% | 0.00% | – |
| Q4 2017 | $1,423,000 | -17.9% | 121,075 | -0.9% | 0.00% | -100.0% |
| Q3 2017 | $1,734,000 | +0.9% | 122,220 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,719,000 | -15.2% | 122,220 | +0.6% | 0.00% | 0.0% |
| Q1 2017 | $2,028,000 | +11.2% | 121,532 | +10.0% | 0.00% | 0.0% |
| Q4 2016 | $1,824,000 | +63.6% | 110,497 | +32.3% | 0.00% | 0.0% |
| Q3 2016 | $1,115,000 | +168.0% | 83,519 | +32.7% | 0.00% | – |
| Q2 2016 | $416,000 | -25.0% | 62,949 | 0.0% | 0.00% | – |
| Q1 2016 | $555,000 | -13.8% | 62,949 | +21.8% | 0.00% | – |
| Q4 2015 | $644,000 | -2.7% | 51,681 | +9.7% | 0.00% | – |
| Q3 2015 | $662,000 | +496.4% | 47,103 | +192.3% | 0.00% | – |
| Q2 2015 | $111,000 | -19.6% | 16,116 | 0.0% | 0.00% | – |
| Q1 2015 | $138,000 | +15.0% | 16,116 | 0.0% | 0.00% | – |
| Q4 2014 | $120,000 | +12.1% | 16,116 | 0.0% | 0.00% | – |
| Q3 2014 | $107,000 | – | 16,116 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|